✦ LIBER ✦

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

✍ Scribed by Marchelle I. Allen; Manon Deslauriers; C. Webster Andrews; Graham A. Tipples; Kathie-Anne Walters; David L. Tyrrell; Nathaniel Brown; Lynn D. Condreay

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 282 KB
Volume: 27
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510270628

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutation pattern of lamivudine resistanc

Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: Hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern

✍ Hans Damerow; Lilly Yuen; Johannes Wiegand; Christine Walker; C.-Thomas Bock; St 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract Little is known about differences between individual hepatitis B genotypes and mutation patterns associated with lamivudine resistance. This study analyses the lamivudine‐associated mutation pattern in relation to the four major HBV genotypes A–D. The PubMed database was screened for ke

Susceptibility of hepatitis B virus to l

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir

✍ H.L. Zaaijer; R.B. Takkenberg; C.J. Weegink; S.P.H. Rebers; S. Menting; H.W. Ree 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract Serial monotherapy and add‐on regimes for treatment of chronic hepatitis B virus (HBV) infection may induce the accumulation of viral resistance mutations in patients, reducing the options for ongoing viral suppression. The induction of antiviral resistance by serial application of poly

Long-term incidence of hepatitis B virus

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients

✍ Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Di Martino; Eric Caumes; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin

Comparison of adefovir and tenofovir in

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

✍ Florian van Bömmel; Thomas Wünsche; Stefan Mauss; Petra Reinke; Alexandra Bergk; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Adefovir dipivoxil was recently approved for the treatment of wild-type and lamivudineresistant hepatitis B virus (HBV) infection. Tenofovir disoproxil fumarate, a congender of adefovir that is used in the treatment of HIV infected patients, has recently been shown to also be effective in patients w

Lamivudine resistance mutations in Europ

Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B

✍ Lucia Taramasso; Patrizia Caligiuri; Antonio Di Biagio; Bianca Bruzzone; Raffael 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract Evaluation of resistance pattern in patients with chronic hepatitis B. Retrospective study of hepatitis B virus (HBV) resistance mutations in patients found viraemic after first‐line treatment. HBV viral load was determined by a real‐time polymerase chain reaction and the substitutions

The real danger of lamivudine-resistant

The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host

✍ Hugo E. Vargas 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Background: In many transplant centres lamivudine is an important component of prophylaxis against, and treatment of, hepatitis B virus (HBV) graft infection. Drug resistant HBV species with specific polymerase mutations may emerge during lamivudine treatment. Aims: To examine the clinical consequen